Related references
Note: Only part of the references are listed.Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer
Naomi B. Boekel et al.
BRITISH JOURNAL OF CANCER (2018)
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)
Jose Luis Zamorano et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Radiotherapy-induced global and regional differences in early-stage left-sided versus right-sided breast cancer patients: speckle tracking echocardiography study
Suvi Sirkku Tuohinen et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2017)
Long-term outcome of cardiac function in a population-based cohort of breast cancer survivors: A cross-sectional study
Liselotte M. Boerman et al.
EUROPEAN JOURNAL OF CANCER (2017)
Strain Imaging Detects Dose-Dependent Segmental Cardiac Dysfunction in the Acute Phase After Breast Irradiation
Queenie Lo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Saro H. Armenian et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study
Tadafumi Sugimoto et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2017)
Detailed Echocardiographic Phenotyping in Breast Cancer Patients: Associations With Ejection Fraction Decline, Recovery, and Heart Failure Symptoms Over 3 Years of Follow-Up
Hari K. Narayan et al.
CIRCULATION (2017)
Myocardial strain imaging: how useful is it in clinical decision making?
Otto A. Smiseth et al.
EUROPEAN HEART JOURNAL (2016)
The Temporal Risk of Heart Failure Associated With Adjuvant Trastuzumab in Breast Cancer Patients: A Population Study
Hart A. Goldhar et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
The Temporal Risk of Heart Failure Associated With Adjuvant Trastuzumab in Breast Cancer Patients: A Population Study
Hart A. Goldhar et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Myocardial Strain Is Associated with Adverse Clinical Cardiac Events in Patients Treated with Anthracyclines
Mohammed T. Ali et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2016)
Doxorubicin-induced cardiac dysfunction in unselected patients with a history of early-stage breast cancer
Megan E. V. Caram et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Roberto M. Lang et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2015)
Predictors of late-onset heart failure in breast cancer patients treated with doxorubicin
Angel Qin et al.
JOURNAL OF CANCER SURVIVORSHIP (2015)
Use of Myocardial Strain Imaging by Echocardiography for the Early Detection of Cardiotoxicity in Patients During and After Cancer Chemotherapy
Paaladinesh Thavendiranathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
Bonnie Ky et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Juan Carlos Plana et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2014)
Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
Heloisa Sawaya et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2012)
Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Edward H. Romond et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
Erin J. Aiello Bowles et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
K. Albain et al.
LANCET (2012)
The Utility of Cardiac Biomarkers, Tissue Velocity and Strain Imaging, and Cardiac Magnetic Resonance Imaging in Predicting Early Left Ventricular Dysfunction in Patients With Human Epidermal Growth Factor Receptor II-Positive Breast Cancer Treated With Adjuvant Trastuzumab Therapy
Nazanin Fallah-Rad et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on southwest oncology group protocol s8897
Patricia A. Ganz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Long-term cardiac toxicity after adjuvant epirubicin-based chemotherapy in early breast cancer: French Adjuvant Study Group Results
P Fumoleau et al.
ANNALS OF ONCOLOGY (2006)
Reversibility of trastuzumab-related cardiotoxicity: New insights based on clinical course and response to medical treatment
MS Ewer et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
N-terminal pro-B-type natriuretic peptide after high-dose chemotherapy: A marker predictive of cardiac dysfunction?
MT Sandri et al.
CLINICAL CHEMISTRY (2005)
Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer:: French adjuvant study group
J Bonneterre et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Congestive heart failure in patients treated with doxorubicin - A retrospective analysis of three trials
SM Swain et al.
CANCER (2003)
Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation
M Zambetti et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
